Territory Manager
$130k - $165k+ Performance-based incentive plans
Mid
Bachelor's
Remote in USA
RemoteRequires up to 60% travel within the assigned territory.
Sales & Account ManagementField Sales
About the job
Requirements
- A bachelor's degree or equivalent experience is required.
- A proven track record of achieving or exceeding sales goals and building strong customer relationships.
- Strong clinical acumen and the ability to communicate complex scientific information.
- Excellent territory planning, organizational, and communication skills.
- A self-motivated, entrepreneurial mindset and the ability to thrive in a fast-paced launch environment.
- A valid driver's license and willingness to travel within the territory.
Responsibilities
- Develop and maintain a strong understanding of the disease state, clinical data, and relevant treatment guidelines.
- Build and execute a comprehensive territory business plan aligned with brand strategy, launch priorities, and sales objectives.
- Drive product adoption and compliant utilization among targeted healthcare providers.
- Analyze territory trends, customer needs, and competitive activity to identify opportunities and course-correct as needed.
- Consistently deliver against sales goals, call activity expectations, and launch milestones.
- Maintain accurate territory reporting and customer relationship management documentation.
- Execute strategic call plans by translating data and insights into impactful, customer-focused actions.
- Build and sustain trusted relationships with healthcare providers, office staff, and key decision-makers.
- Clearly and compliantly communicate clinical data, product value, access information, and appropriate patient identification.
- Deliver engaging, high-quality product presentations and address customer questions with confidence and credibility.
- Partner with customers to address barriers to patient access and support product pull-through.
- Partner effectively with cross-functional stakeholders to understand customer needs and elevate the customer and patient experience in a compliant manner.
- Collaborate with adjacent field partners, including Field Reimbursement Managers, Territory Managers, and Regional Business Directors, to support customer needs and territory objectives.
- Share insights, learnings, and best practices with field leadership and internal teams, including Marketing, Training, Field Operations, and Analytics.
- Provide timely market intelligence, customer insights, and competitive updates.
- Support regional meetings, launch initiatives, and company-sponsored programs.
- Operate with integrity and in compliance with company policies, industry regulations, and legal requirements.
- Demonstrate professionalism, accountability, and ethical conduct in all customer interactions.
- Consistently embody the company's values of collaboration, integrity, quality, trust, and urgency.
Desired Qualifications
- Three or more years of pharmaceutical or biotechnology sales experience; other relevant sales experience will also be considered.
- Specialty sales experience in cardiometabolic markets.
- Prior product launch experience.
About the company
Mineralys Therapeutics develops targeted treatments for diseases driven by dysregulated aldosterone to help lower blood pressure. Its lead drug, lorundrostat, is an oral aldosterone synthase inhibitor that blocks the CYP11B2 enzyme to reduce aldosterone production, with high selectivity over cortisol. It is advancing through late-stage trials (Phase 3) to treat hypertension-related conditions, CKD, and potentially OSA, using funds from its IPO to support trials, manufacturing, and commercialization preparation. By focusing on a selective mechanism that avoids large cortisol disruption, Mineralys differentiates itself from older MRAs and aims to address a large potential market, estimated to exceed $200 billion by 2030.
Company Size
51-200
Company Stage
IPO
Headquarters
Radnor Township, Pennsylvania
Founded
2020
Get referred to Mineralys Therapeutics
See people who can refer or advise you
Simplify's Take
What believers are saying
- FDA accepted lorundrostat NDA on March 9, 2026, with December 22 PDUFA.
- Q2 2026 showed commercial readiness: sales hiring, market access, and payer engagement.
- Lorundrostat posted 52.2% placebo-adjusted UACR reduction in CKD albuminuria at 12 weeks.
What critics are saying
- AstraZeneca's Baxfendy approved May 18, 2026, grabbing first-mover advantage before Mineralys.
- December 22, 2026 PDUFA leaves one binary FDA decision; rejection kills the launch.
- If lorundrostat misses approval, Mineralys becomes a cash-burning single-asset biotech.
What makes Mineralys Therapeutics unique
- Lorundrostat directly inhibits CYP11B2, targeting aldosterone source instead of receptor blockade.
- Launch-HTN enrolled 800 patients and showed CKD-aligned blood-pressure and albuminuria reductions.
- Mineralys now owns lorundrostat royalties and IP after the June 2026 Tanabe buyout.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- 401(k) Retirement Plan
- Remote Work Options
- Unlimited Paid Time Off
- Flexible Work Hours
- Hybrid Work Options
- 401(k) Company Match
- Wellness Program
- Mental Health Support
- Gym Membership